<SEC-DOCUMENT>0001213900-25-092533.txt : 20250929
<SEC-HEADER>0001213900-25-092533.hdr.sgml : 20250929
<ACCEPTANCE-DATETIME>20250926191259
ACCESSION NUMBER:		0001213900-25-092533
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250929
DATE AS OF CHANGE:		20250926

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kindly MD, Inc.
		CENTRAL INDEX KEY:			0001946573
		STANDARD INDUSTRIAL CLASSIFICATION:	FINANCE SERVICES [6199]
		ORGANIZATION NAME:           	09 Crypto Assets
		EIN:				843829824
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-274606
		FILM NUMBER:		251351788

	BUSINESS ADDRESS:	
		STREET 1:		5097 SOUTH 900 EAST
		STREET 2:		SUITE 100
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84117
		BUSINESS PHONE:		(385) 388-8220

	MAIL ADDRESS:	
		STREET 1:		5097 SOUTH 900 EAST
		STREET 2:		SUITE 100
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84117
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>ea025907103-424b3_kindly.htm
<DESCRIPTION>PROSPECTUS SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PROSPECTUS&nbsp;SUPPLEMENT</B></FONT></TD>
    <TD STYLE="width: 40%; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Filed Pursuant to 424(b)(3)</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>To Prospectus dated May 6, 2025</B></FONT></TD>
    <TD STYLE="width: 40%; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Registration No. 333-274606</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>KINDLY MD, INC.</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><IMG SRC="image_001.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2,059,811 Shares of Common Stock Issuable Upon
Exercise of Previously Issued Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>and</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>82,310 Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus supplement updates and supplements
the information contained in the prospectus dated May 6, 2025 (as may be supplemented or amended from time to time, the &ldquo;Prospectus&rdquo;),
which forms part of our registration statement on Form S-1 (File No. 333-274606), as amended, with the information contained in our Current
Report on Form 8-K which was filed with the Securities and Exchange Commission on September 16, 2025 (the &ldquo;Current Report&rdquo;).
Accordingly, we have attached the Current Report to this prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Prospectus and this prospectus supplement
relate to the issuance by Kindly MD, Inc., a Utah corporation, of up to 2,059,811 shares of common stock underlying the tradeable warrants
(the &ldquo;Tradeable Warrants&rdquo;), the non-tradeable warrants (the &ldquo;Non-tradeable Warrants&rdquo;) and the representative&rsquo;s
warrants (the &ldquo;Representative&rsquo;s Warrants&rdquo; and, together with the Tradeable Warrants and the Non-tradeable Warrants,
the &ldquo;Warrants&rdquo;) previously issued by us in our initial public offering that closed on June 3, 2024. We are not selling any
shares of our common stock in this offering, and, as a result, we will not receive any proceeds from the sale of the common stock covered
by this prospectus. All of the net proceeds from the sale of our common stock will go to the holders of the Warrants. Upon exercise of
the Warrants, however, we will receive proceeds from the exercise of such Warrants if exercised for cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Prospectus and the prospectus supplement also
relate to the resale from time to time by the selling stockholders named in the Prospectus (the &ldquo;Selling Stockholders&rdquo;) of
82,310 shares of common stock. We will not receive any proceeds from the sale of shares of common stock by the Selling Stockholders pursuant
to the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should read this prospectus supplement in
conjunction with the Prospectus. This prospectus supplement is qualified by reference to the Prospectus except to the extent that the
information in this prospectus supplement supersedes the information contained in the Prospectus. This prospectus supplement is not complete
without, and may not be delivered or utilized except in connection with, the Prospectus. If there is any inconsistency between the information
in the Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement. Terms used in this
prospectus supplement but not defined herein shall have the meanings given to such terms in the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our common stock is listed on the Nasdaq Capital
Market (&ldquo;Nasdaq&rdquo;) under the symbol &ldquo;NAKA.&rdquo; The last reported sale price of our common stock on Nasdaq on September
26, 2025 was $1.15 per share. Our Tradeable Warrants, previously listed on Nasdaq under the symbol &ldquo;NAKAW,&rdquo; have been delisted
from Nasdaq and are now quoted on the OTC Pink marketplace under the symbol &ldquo;NAKAW.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investing in our securities involves a high
degree of risk. See &ldquo;Risk Factors&rdquo; beginning on page 10 of the Prospectus and in the other documents that are incorporated
by reference in the Prospectus.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of the securities to be issued under the Prospectus or determined if the
Prospectus or this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The date of this prospectus supplement is September
26, 2025.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT<BR>
PURSUANT TO SECTION 13 OR 15(d) OF<BR>
THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<B>September 15, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Kindly MD, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; width: 49%"><FONT STYLE="font-size: 10pt"><B>001-42103</B></FONT></TD>
    <TD STYLE="width: 2%">&#160;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; width: 49%"><FONT STYLE="font-size: 10pt"><B>84-3829824</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Commission File Number)</FONT></TD>
    <TD>&#160;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(IRS Employer Identification Number)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&#160;</TD>
    <TD>&#160;</TD>
    <TD STYLE="text-align: center">&#160;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>5097 South 900 East, Suite 100, Salt Lake City, UT</B></FONT></TD>
    <TD>&#160;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>84117</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Address of Principal Executive Offices)</FONT></TD>
    <TD>&#160;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Zip Code)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(385) 388-8220</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B>(Registrant&#8217;s telephone number, including area code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><FONT STYLE="text-decoration: underline">N/A</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><FONT STYLE="text-decoration: underline"></FONT></B>(Former name or former address, if changed since last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR240.14d-2(b))</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR240.13e-4(c))</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><FONT STYLE="font-size: 10pt"><B>Title of Each Class</B></FONT></TD>
    <TD STYLE="text-align: center; width: 2%">&#160;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><FONT STYLE="font-size: 10pt"><B>Trading Symbol(s)</B></FONT></TD>
    <TD STYLE="text-align: center; width: 2%">&#160;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><FONT STYLE="font-size: 10pt"><B>Name of Each Exchange on Which Registered</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Common Stock, par value $0.001</FONT></TD>
    <TD STYLE="text-align: center">&#160;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">NAKA</FONT></TD>
    <TD STYLE="text-align: center">&#160;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">The Nasdaq Stock Market LLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Tradeable Warrants to purchase shares of Common Stock, par value $0.001 per share</FONT></TD>
    <TD STYLE="text-align: center">&#160;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">NAKAW</FONT></TD>
    <TD STYLE="text-align: center">&#160;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">OTC Pink Market</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR &#167;240.12b-2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 8.01 Other Events.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 15, 2025, Kindly MD, Inc., a Utah
corporation (the &#8220;<B>Company</B>&#8221;) issued a notice of redemption (&#8220;<B>Redemption Notice</B>&#8221;) to the holder of its
Secured Convertible Debenture, dated August 15, 2025 (the &#8220;<B>Debenture</B>&#8221;), in accordance with Section 2(a)(i) of the Debenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Redemption Notice, on September 29, 2025 (the &#8220;<B>Redemption
Date</B>&#8221;) the Company will redeem all amounts outstanding under the Debenture that have not been converted prior to or on the Redemption
Date in cash equal to 100% of the outstanding principal amount of the Debenture, plus a 1.5% payment premium, with any such cash amounts
delivered to the holder of the Debenture on September 30, 2025. If the holder of the Debenture does not elect to convert the Debenture,
the total redemption amount plus 1.5% payment premium would be equal to $203,000,000. There will be no accrued or unpaid interest due
and payable under the Debenture as of the Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A copy of the Debenture is attached hereto as
Exhibit 4.1 to this Current Report on Form 8-K and is incorporated into this Item 8.01 by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 9.01 Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d) Exhibits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: top; width: 9%"><FONT STYLE="font-size: 10pt"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1pt; width: 1%">&#160;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 90%"><FONT STYLE="font-size: 10pt"><B>Description of Exhibit</B></FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top"><FONT STYLE="font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="vertical-align: bottom">&#160;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1946573/000121390025077579/ea025298001ex4-1_kindly.htm">Secured Convertible Debenture, dated August 15, 2025 (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K, filed with the SEC on August 15, 2025)</A></FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top"><FONT STYLE="font-size: 10pt">104</FONT></TD>
    <TD STYLE="vertical-align: bottom">&#160;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">The cover page from this Current Report on Form
    8-K, formatted in Inline XBRL.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunder
duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&#160;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">KINDLY MD, INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 60%">&#160;</TD>
    <TD STYLE="width: 3%">&#160;</TD>
    <TD STYLE="text-align: justify; width: 37%">&#160;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Dated: September 16, 2025</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">By<I>: </I></FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-size: 10pt">/s/ David Bailey</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&#160;</TD>
    <TD>&#160;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">David Bailey</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&#160;</TD>
    <TD>&#160;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</P>


<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  S -H# 2(  A$! Q$!_\0
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MC/ ECH.@1:Q<:=K(O(!+OG8@@1 9Z^I]ZV6^(?A5(5E;6;;:Q(&"2>/:O/O
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E44 %%%% !1110 4444  HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
